Skip to main content

Table 3 Correlation between early tumor shrinkage 6 weeks after treatment and overall response

From: Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer

  

Overall response

Sum

  

Response

Non-response

Early tumor shrinkage

Yes

17

6

23

 

No

13

67

80

Sum

30

73

103

  1. (Correlation coefficient: 0.529, p < 0.001)